Company intelligence / Profile preview

Avid Radiopharmaceuticals

Philadelphia, Pennsylvania, United Statesavidrp.com ↗
Ownership
Private
Employees
~100
Development stage
Other
01

Overview

Avid developed Amyvid® (florbetapir F 18), the first FDA-approved PET imaging agent to detect beta amyloid plaques in living patients, enabling earlier and more accurate diagnosis of Alzheimer’s disease. Its second major product, Tauvid® (flortaucipir F 18), is also FDA-approved for imaging tau pathology. The company has additional agents in clinical development targeting neurodegenerative diseases and diabetes. Clinical results have shown these tracers can reliably identify hallmark pathologies of Alzheimer's and related conditions, supporting their use in both research and clinical practice[1][3][8].

Therapeutic areas
EndocrinologyPsychiatryNeurology
Modalities
Diagnostic radiopharmaceuticalsSmall molecules[6][10]
Industry
Biotech
02

Drug pipeline

8 assets

flortaucipir f-18

Approved

7 more assets in the full pipeline.

03

Partnerships

– University of Pennsylvania for technology licensing[1]– Academic collaborations including Johns Hopkins Hospital, Skåne University Hospital, ADNI initiative support [1][9][10]

Beyond the preview

Go deeper on Avid Radiopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avid Radiopharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call